2016 International Congress Archives - Page 28 of 207

12:30pm-2:00pm: Inhibition of nociceptive responses by modulating serotonergic signals at the rostral ventromedial medulla in 6-OHDA-induced Parkinson’s disease rat model

C. Wang, C. Mao, F. Wang, J. Yang, X. Zhang, Y. Yang, C. Liu (Suzhou, People's Republic of China)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Innsbruck multiple system atrophy cohort study – An interim analysis

S. Eschlböck, T. Benke, S. Bösch, A. Djamshidian-Tehrani1, A. Fanciulli, R. Granata, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

Parkinsonism, MSA, PSP

12:30pm-2:00pm: Introducing the 2nd edition of the occupational therapy for people with Parkinson’s: Best practice guidance

A. Aragon (Bath, United Kingdom)

Education in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?

M. Hahne, D. Hartmann, C. Thomopoulos, A. Ramih, M. Esther, Y. Guangji, G. Bernd, W. Dirk, R. Heinz, J. Wolfgang (Bad Neustadt, Germany)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Is the PPN a valuable target for deep brain stimulation in treatment of Parkinsonian disorders? Experience of a patient’s series

I. Galazky, A. Kupsch, E. Wirkus, F. Casjens, S. Specht, H.J. Heinze, J. Voges (Magdeburg, Germany)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Is there any relationship between olfactory dysfunction and memory disorder?

H. Onuma, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara-city, Japan)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2